JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    •   OpenBU
    • School of Medicine
    • Clinical Science
    • Department of Neurology
    • MED: Neurology Papers
    • View Item
    •   OpenBU
    • School of Medicine
    • Clinical Science
    • Department of Neurology
    • MED: Neurology Papers
    • View Item

    Modulators of Cytoskeletal Reorganization in CA1 Hippocampal Neurons Show Increased Expression in Patients at Mid-Stage Alzheimer's Disease

    Thumbnail
    Download/View
    pone.0013337.pdf (3.644Mb)
    Date Issued
    2010-10-13
    Related DOI
    10.1371/journal.pone.0013337
    Author
    Kao, Patricia F.
    Davis, David A.
    Banigan, Meredith G.
    Vanderburg, Charles R.
    Seshadri, Sudha
    Delalle, Ivana
    Share to FacebookShare to TwitterShare by Email
    Export Citation
    Download to BibTex
    Download to EndNote/RefMan (RIS)
    Metadata
    Show full item record
    Permanent Link
    https://hdl.handle.net/2144/3188
    Citation
    Kao, Patricia F., David A. Davis, Meredith G. Banigan, Charles R. Vanderburg, Sudha Seshadri, Ivana Delalle. "Modulators of Cytoskeletal Reorganization in CA1 Hippocampal Neurons Show Increased Expression in Patients at Mid-Stage Alzheimer's Disease" PLoS ONE 5(10): e13337. (2010)
    Abstract
    During the progression of Alzheimer's disease (AD), hippocampal neurons undergo cytoskeletal reorganization, resulting in degenerative as well as regenerative changes. As neurofibrillary tangles form and dystrophic neurites appear, sprouting neuronal processes with growth cones emerge. Actin and tubulin are indispensable for normal neurite development and regenerative responses to injury and neurodegenerative stimuli. We have previously shown that actin capping protein beta2 subunit, Capzb2, binds tubulin and, in the presence of tau, affects microtubule polymerization necessary for neurite outgrowth and normal growth cone morphology. Accordingly, Capzb2 silencing in hippocampal neurons resulted in short, dystrophic neurites, seen in neurodegenerative diseases including AD. Here we demonstrate the statistically significant increase in the Capzb2 expression in the postmortem hippocampi in persons at mid-stage, Braak and Braak stage (BB) III-IV, non-familial AD in comparison to controls. The dynamics of Capzb2 expression in progressive AD stages cannot be attributed to reactive astrocytosis. Moreover, the increased expression of Capzb2 mRNA in CA1 pyramidal neurons in AD BB III-IV is accompanied by an increased mRNA expression of brain derived neurotrophic factor (BDNF) receptor tyrosine kinase B (TrkB), mediator of synaptic plasticity in hippocampal neurons. Thus, the up-regulation of Capzb2 and TrkB may reflect cytoskeletal reorganization and/or regenerative response occurring in hippocampal CA1 neurons at a specific stage of AD progression.
    Rights
    Kao et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
    Collections
    • MED: Neurology Papers [66]
    • MED: Pathology and Laboratory Medicine Papers [26]

    Contact Us | Send Feedback | Help
     

     

    Browse

    All of OpenBUCommunities & CollectionsIssue DateAuthorsTitlesSubjectsThis CollectionIssue DateAuthorsTitlesSubjects

    Deposit Materials

    LoginNon-BU Registration

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Contact Us | Send Feedback | Help